Your session is about to expire
← Back to Search
Behavioral Intervention
Sarcoidosis Patient Assessment and Resource Companion App for Sarcoidosis (SPARC Trial)
N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the duration of the study, approximately 6 months
Awards & highlights
Summary
This trial will evaluate whether a smartphone app can help manage stress and fatigue for people with sarcoidosis.
Eligible Conditions
- Sarcoidosis
- Fatigue
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ throughout the duration of the study, approximately 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the duration of the study, approximately 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants who achieve treatment satisfaction
Number of participants who complete the study
Number of participants who maintain adherence to twice daily breathing awareness meditation sessions
+1 moreSecondary outcome measures
Change in Sarcoidosis Associated Fatigue
Changes in Autonomous Motivation
Changes in Quality of Life
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SPARC GroupExperimental Treatment1 Intervention
Group II: Enhanced Standard Care Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sarcoidosis Patient Assessment and Resource Companion App
2022
N/A
~50
Find a Location
Who is running the clinical trial?
National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
90 Previous Clinical Trials
19,878 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
947 Previous Clinical Trials
7,398,018 Total Patients Enrolled
3 Trials studying Sarcoidosis
51 Patients Enrolled for Sarcoidosis
Share this study with friends
Copy Link
Messenger